Concepedia

Michelle L. VanLith

ML

6

Publications

435

Citations

6

H-Index

1998

Active since

Affiliations

University of Nebraska Medical Center(Current)

Mayo Clinic in Arizona

Nebraska Medical Center

Michelle L. VanLith is an author at University of Nebraska Medical Center specializing in cell biology, medicine, and immunology.

Top concepts

MedicineCell BiologyImmunologyImmunotherapyTumor BiologyTumor ImmunityCancer BiologyTumor MicroenvironmentEngineeringAutoimmunity

Publications per year

1998–2006

6

Publications

6

Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model.

Gerald J. Rowse, Richard M. Tempero, Michelle L. VanLith et al. · PubMed · 1998 · 208 citations

Immune Regulation, Immunology, Immunologic Mechanism +19

The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis

Nicolas Moniaux, Christophe Némos, Bruno M. Schmied et al. · Oncogene · 2006 · 94 citations

Systems Biology, Engineering, Medicine +10

CD4+ Lymphocytes Provide MUC1-Specific Tumor Immunity In Vivo That Is Undetectable In Vitro and Is Absent in MUC1 Transgenic Mice

Richard M. Tempero, Michelle L. VanLith, Keita Morikane et al. · The Journal of Immunology · 1998 · 66 citations · Full text

Cancer Immunosurveillance, Human Muc1, Vivo That +14

Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1)

Karl G. Kohlgraf, Andrew J. Gawron, Michiyo Higashi et al. · Cancer Immunology Immunotherapy · 2004 · 33 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immunology +11

MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses

Michelle L. VanLith · International Immunology · 2002 · 19 citations · Full text

Rows per page

1–5 of 6